Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3’,5’-bisphosphate as a potent enzyme inhibitor
G.J. Lockbaum(Accent Therapeutics (United States)), P. Ann Boriack‐Sjodin(Accent Therapeutics (United States))
Cited by 1
Related Papers
The structural basis of the activation of Ras by Sos
|Nature|1998|801
Structure-based Mutagenesis Reveals Distinct Functions for Ras Switch 1 and Switch 2 in Sos-catalyzed Guanine Nucleotide Exchange
|Journal of Biological Chemistry|2001|127